Respira Therapeutics Inc.'s method for delivering drugs to the lung is unusual because it does not utilize any chemical and doesn't require special formulations. Instead, a drug-coated bead about the size of a pea sits dead center in a cartridge the size and shape of a lipstick tube. When a person inhales from the device, the bead oscillates and the therapeutic is detached as the patient breathes in.
11412 Bee Caves Road
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
The AstraZeneca CEO again calls for rich European countries to pay more for new drugs because "a model where the US funds innovation in our industry for the entire world doesn't work."
The AKT inhibitor proves ineffective for metastatic castration-resistant disease in a Phase III trial.
First-quarter results season featured tariff talk but without any full-year quantitation. As tariffs and foreign exchange movements bump up against capped drug prices, profitability could suffer.
